Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2228 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 |
filingDate |
2012-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de97db40474041fdf29ee6b12a6c56d5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85c8870cc7f46941278ac65b99e3a965 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_101715a5f50e6ff4a779652b17f2004f |
publicationDate |
2012-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CO-6541617-A2 |
titleOfInvention |
METHOD OF TREATMENT OF HEART FAILURE WITH STRESTRINE TYPE PEPTIDES |
abstract |
The present invention relates to new methods for treating heart failure; The methods comprise administering an amount of a peptide type to a subject that requires it and practically maintaining the amount of the peptide present in the subject's plasma at a concentration that produces a therapeutic benefit without a substantial increase in the subject's heart rate. The method involves the use of strescopin-like peptides that are selective agonists of the type 2 corticotropin release hormone receptor (CRHR2). |
priorityDate |
2009-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |